Boiron 

$31.50
84
+$0.00+0% Monday 15:27

統計

當日最高
31.5
當日最低
31.5
52週高點
32.28
52週低點
24
成交量
400
平均成交量
4
市值
552.67M
本益比
24.06
股息殖利率
4.94%
股息
1.56

即將到來

股息

4.94%股息殖利率
Jun 26
$1.56
Jun 25
$1.37
Jun 24
$1.47
Oct 23
$10.99
Jun 23
$1.18
10年成長
-0.91%
5年成長
6.12%
3年成長
9.65%
1年成長
13.22%

財報

18Sep預期
Q1 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q1 2025
Q2 2025
0
0.33
0.67
1
預期EPS
不適用
實際EPS
不適用

財務

6.51%利潤率
有盈利
2020
2021
2022
2023
2024
2025
589.28M營收
38.36M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 BOIRF 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Boiron S.A. is a leading pharmaceutical enterprise focused on the global development and sale of homeopathic treatments. Its market presence extends across France, the wider European continent, North America, and numerous international territories. The company's offerings comprise a diverse array of homeopathic products, including both non-proprietary and branded formulations. Notable examples from its brand portfolio target specific health concerns: Oscillococcinum is formulated to alleviate symptoms associated with influenza, such as fever, chills, headaches, and general body aches. Stodal and Stodaline are designed for the symptomatic relief of coughs. Arnigel provides topical support for minor, non-open traumatic injuries. Camilia is specifically developed to soothe teething discomfort in infants. Sédatif PC addresses anxiety, emotional imbalances, and mild sleep disturbances. Coryzalia helps manage cold symptoms and rhinitis. Homéoptic offers relief for various types of eye irritation and discomfort in both adults and children. Homéovox is aimed at vocal disorders. Beyond its core homeopathic line, Boiron provides a range of supplementary health products. These include dietary supplements; the Dermoplasmine collection (available as stick, balm, and mousse) for dry lips and skin; Mag' Nuit, designed to aid sleep; Arnitrosium for joint pain; Castor Equi Boiron ointment to treat cracked skin; and Storinil, a syrup for cold treatment. Furthermore, the company produces herbal medicines, such as Canephron, which supports increased urine production and improved urinary elimination. Its product list also features moisturizing baby milk and a selection of medical devices, including COVID-19 self-tests and rapid antigenic tests. Boiron distributes its extensive product portfolio through a wide network, encompassing its own distribution centers, independent pharmacies, large pharmacy chains, wholesalers, grocery stores, specialized health food retailers, and online sales platforms. Established in 1932, Boiron S.A. maintains its corporate headquarters in Messimy, France.
Show more...
執行長
Mr. Thierry Boiron
員工
2469
國家
法國
ISIN
FR0000061129

上市

0 Comments

分享你的想法

FAQ

Boiron 今天的股價是多少?
BOIRF 目前價格為 $31.50 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Boiron 股價表現。
Boiron 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,Boiron 的股票以代號 BOIRF 進行交易。
Boiron 的市值是多少?
今天 Boiron 的市值為 552.67M
Boiron 去年的營收是多少?
Boiron 去年的營收為 589.28MUSD。
Boiron 去年的淨利是多少?
BOIRF 去年的淨收益為 38.36MUSD。
Boiron 會發放股息嗎?
是的,BOIRF 的股息每 年度 發放一次。每股最新股息為 1.56 USD。截至今日,股息殖利率(FWD)% 為 4.94%。
Boiron 有多少名員工?
截至 July 29, 2026,公司共有 2,469 名員工。
Boiron 位於哪個產業?
Boiron從事於Health & Wellness產業。
Boiron 何時完成拆股?
Boiron 最近沒有進行任何拆股。
Boiron 的總部在哪裡?
Boiron 的總部位於 法國 的 Messimy。